NCT00062270View on ClinicalTrials.gov

Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

docetaxel

DRUG

gefitinib

DRUG

gemcitabine hydrochloride

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

RADIATION

radiation therapy

Trial Locations (1)

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00062270 - Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter